Genetic deficiency of C3 as well as CNS-targeted expression of the complement inhibitor sCrry ameliorates experimental autoimmune uveoretinitis

Experimental Eye Research

Volumn 82, Issue 3, 2006, Pages 389-394

  Read, Russell W ^a,b,c   Szalai, Alexander J ^d   Vogt, Susan D ^a   McGwin, Gerald ^a,e,f   Barnum, Scott R ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f Kentucky   (United States)

Author keywords

Complement; Experimental autoimmune uveoretinitis; Glial fibrillary acidic protein; Transgenic

Indexed keywords

AMINO ACID DERIVATIVE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT INHIBITOR; COMPLEMENT RECEPTOR; FREUND ADJUVANT; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; LIGANDIN; PEPTIDE DERIVATIVE; PERTUSSIS TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; COMPLEMENT ACTIVATION; COMPLEMENT DEFICIENCY; COMPLEMENT INHIBITION; CONTROLLED STUDY; DISEASE SEVERITY; MORBIDITY; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; UVEORETINITIS; WESTERN BLOTTING; WILD TYPE;

ANIMALS; AUTOIMMUNE DISEASES; BLOTTING, WESTERN; CENTRAL NERVOUS SYSTEM; COMPLEMENT C3; GENE EXPRESSION; GENE TARGETING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; RECEPTORS, COMPLEMENT; RETINA; RETINITIS; UVEITIS;

EID: 31344433995     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2005.07.011     Document Type: Article

References (28)

1. D. Avichezer, P.B. Silver, C.C. Chan, B. Wiggert, and R.R. Caspi Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype Invest. Ophthalmol. Vis. Sci. 41 2000 127 131
2. D.S. Bardenstein, C.J. Cheyer, C. Lee, E. Cocuzzi, M. Mizuno, N. Okada, and M.E. Medof Blockage of complement regulators in the conjunctiva and within the eye leads to massive inflammation and iritis Immunology 104 2001 423 430
3. L. Boos, I.L. Campbell, R. Ames, R.A. Wetsel, and S.R. Barnum Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis J. Immunol. 173 2004 4708 4714
4. R.R. Caspi, F.G. Roberge, C.G. McAllister, M. el-Saied, T. Kuwabara, I. Gery, E. Hanna, and R.B. Nussenblatt T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat J. Immunol. 136 1986 928 933
5. C.C. Chan, R.R. Caspi, M. Ni, W.C. Leake, B. Wiggert, G.J. Chader, and R.B. Nussenblatt Pathology of experimental autoimmune uveoretinitis in mice J. Autoimmun. 3 1990 247 255
6. A. Circolo, G. Garnier, W. Fukuda, X. Wang, T. Hidvegi, A.J. Szalai, D.E. Briles, J.E. Volanakis, R.A. Wetsel, and H.R. Colten Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA Immunopharmacology 42 1999 135 149
7. N. Davoust, S. Nataf, R. Reiman, M.V. Holers, I.L. Campbell, and S.R. Barnum Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis J. Immunol. 163 1999 6551 6556
8. O.M. Durrani, C.A. Meads, and P.I. Murray Uveitis: a potentially blinding disease Ophthalmologica 218 2004 223 236
9. J.A. Ember, M.A. Jagels, and T.E. Hugli Characterization of complement anaphylatoxins and their biological responses J.E. Volanakis M.M. Frank The Human Complement System in Health and Disease 1998 Marcel Dekker New York 241 284
10. D.C. Gritz, and I.G. Wong Incidence and prevalence of uveitis in Northern California; the Northern California epidemiology of uveitis study Ophthalmology 111 2004 491 500 (discussion 500)
11. G.E. Marak, W.B. Wacker, N.A. Rao, R. Jack, and P.A. Ward Effects of complement depletion on experimental allergic uveitis Ophthalmic Res. 11 1979 97 107
12. B.J. Mondino, M.M. Glovsky, and L. Ghekiere Activated complement in inflamed aqueous humor Invest. Ophthalmol. Vis. Sci. 25 1984 871 873
13. B.J. Mondino, Y. Sidikaro, and H. Sumner Anaphylatoxin levels in human vitreous humor Invest. Ophthalmol. Vis. Sci. 29 1988 1195 1198
14. S. Nataf, S.L. Carroll, R.A. Wetsel, A.J. Szalai, and S.R. Barnum Attenuation of experimental autoimmune demyelination in complement- deficient mice J. Immunol. 165 2000 5867 5873
15. R.J. Quigg, and V.M. Holers Characterization of rat complement receptors and regulatory proteins. CR2 and Crry are conserved, and the C3b receptor of neutrophils and platelets is distinct from CR1 J. Immunol. 155 1995 1481 1488
16. R.J. Quigg, C.F. Lo, J.J. Alexander, A.E. Sneed 3rd, and G. Moxley Molecular characterization of rat Crry: widespread distribution of two alternative forms of Crry mRNA Immunogenetics 42 1995 362 367
17. R.J. Quigg, C. He, A. Lim, D. Berthiaume, J.J. Alexander, D. Kraus, and V.M. Holers Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury J. Exp. Med. 188 1998 1321 1331
18. R.J. Quigg, Y. Kozono, D. Berthiaume, A. Lim, D.J. Salant, A. Weinfeld, P. Griffin, E. Kremmer, and V.M. Holers Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor J. Immunol. 160 1998 4553 4560
19. R. Reiman, C. Gerard, I.L. Campbell, and S.R. Barnum Disruption of the C5a receptor gene fails to protect against experimental allergic encephalomyelitis Eur. J. Immunol. 32 2002 1157 1163
20. J.T. Rosenbaum, K. Wong, H.D. Perez, W. Raymond, and E.L. Howes Jr. Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor Invest. Ophthalmol. Vis. Sci. 25 1984 1184 1191
21. J.H. Sohn, H.J. Kaplan, H.J. Suk, P.S. Bora, and N.S. Bora Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins Invest. Ophthalmol. Vis. Sci. 41 2000 3492 3502
22. M. Su, H. Hu, Y. Lee, A. d'Azzo, A. Messing, and M. Brenner Expression specificity of GFAP transgenes Neurochem. Res. 29 2004 2075 2093
23. A.J. Szalai, D.E. Briles, and J.E. Volanakis Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae Infect. Immun. 64 1996 4850 4853
24. A.J. Szalai, F.W. van Ginkel, Y. Wang, J.R. McGhee, and J.E. Volanakis Complement-dependent acute-phase expression of C-reactive protein and serum amyloid P-component J. Immunol. 165 2000 1030 1035
25. R.A. Wetsel, and W.P. Kolb Complement-independent activation of the fifth component (C5) of human complement: limited trypsin digestion resulting in the expression of biological activity J. Immunol. 128 1982 2209 2216
26. R.A. Wetsel, and W.P. Kolb Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments J. Exp. Med. 157 1983 2029 2048
27. R.C. Wiggins, P.C. Giclas, and P.M. Henson Chemotactic activity generated from the fifth component of complement by plasma kallikrein of the rabbit J. Exp. Med. 153 1981 1391 1404
28. L. Zhuo, B. Sun, C.L. Zhang, A. Fine, S.Y. Chiu, and A. Messing Live astrocytes visualized by green fluorescent protein in transgenic mice Dev. Biol. 187 1997 36 42